CYP1A2 and lung cancer: In one recent meta-analysis by Zhi-Bin Bu et al. [86] on the association between CYP1A2 rs762551, rs2069514, rs2069526, and rs2470890 polymorphisms and lung cancer risk, there was no evidence of significant association between lung cancer risk and CYP1A2 rs2069514, s2470890, and rs2069526 polymorphisms.